Skip to main content
. 2020 Aug 25;26(2):371–380. doi: 10.1007/s10741-020-10016-2

Fig. 1.

Fig. 1

RAS system and targets of conventional RAS inhibitors. Ang I, angiotensin I; ACE, angiotensin-converting enzyme; Ang II, angiotensin II; Ang 1–7, angiotensin 1–7; ACEi, ACE inhibitors; MRAs, mineralocorticoid receptor agonists; ARBs, angiotensin II receptor blockers; AT1, Ang II type I receptors